organization · Reporting owner
Double Eagle Investor Holdings, L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Syneos Health, Inc.
Report date June 07, 2021 · Filed June 09, 2021
Jointly reported with ADVENT INTERNATIONAL, L.P., Double Eagle GP, LLC, Advent International GPE VIII-C Limited Partnership, GPE VIII GP S.a.r.l., GPE VIII GP Limited Partnership, Advent International GPE VIII, LLC, GPE VII GP S.a.r.l., GPE VII GP Limited Partnership, Advent International GPE VII, LLC
Section 16 reporting ended · disclosed 2021-06-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Notes | 273,821 |
Reported balance
After 2021-06-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-06-07 · Sale · Disposed 6,033,668 · Balance 273,821 F1: See Exhibit 99.1 for text of footnote (1). F4: See Exhibit 99.1 for text of footnote (4). F5: See Exhibit 99.1 for text of footnote (5). |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Notes | 0 |
Reported balance
After 2021-06-07 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2021-06-07 · Sale · Disposed 273,821 · Balance 0 F3: See Exhibit 99.1 for text of footnote (3). F2: See Exhibit 99.1 for text of footnote (2). F4: See Exhibit 99.1 for text of footnote (4). F5: See Exhibit 99.1 for text of footnote (5). |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1 for text of footnote (1).
F2: See Exhibit 99.1 for text of footnote (2).
F3: See Exhibit 99.1 for text of footnote (3).
F4: See Exhibit 99.1 for text of footnote (4).
F5: See Exhibit 99.1 for text of footnote (5).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2021 Filed Jun 9, 2021 21:38 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 273,821 | $81.20 | $22,234,265.20 |
DisclosureSEC source: 0001140361-21-020402 · form4.xml · nonDerivative · entry 2 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Double Eagle Investor Holdings, L.P. · CIK 0001712399 · 10% owner Double Eagle GP, LLC · CIK 0001712398 · 10% owner Advent International GPE VIII-C Limited Partnership · CIK 0001664591 · 10% owner GPE VIII GP S.a.r.l. · CIK 0001764293 · 10% owner GPE VIII GP Limited Partnership · CIK 0001714525 · 10% owner Advent International GPE VIII, LLC · CIK 0001713142 · 10% owner GPE VII GP S.a.r.l. · CIK 0001764292 · 10% owner GPE VII GP Limited Partnership · CIK 0001616580 · 10% owner Advent International GPE VII, LLC · CIK 0001616626 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 0 F3 · kind: See Exhibit 99.1 for text of footnote (3). F2 · shares: See Exhibit 99.1 for text of footnote (2). F3 · balance_after: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 21:38 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 6,033,668 | $81.20 | $489,933,841.60 |
DisclosureSEC source: 0001140361-21-020402 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Double Eagle Investor Holdings, L.P. · CIK 0001712399 · 10% owner Double Eagle GP, LLC · CIK 0001712398 · 10% owner Advent International GPE VIII-C Limited Partnership · CIK 0001664591 · 10% owner GPE VIII GP S.a.r.l. · CIK 0001764293 · 10% owner GPE VIII GP Limited Partnership · CIK 0001714525 · 10% owner Advent International GPE VIII, LLC · CIK 0001713142 · 10% owner GPE VII GP S.a.r.l. · CIK 0001764292 · 10% owner GPE VII GP Limited Partnership · CIK 0001616580 · 10% owner Advent International GPE VII, LLC · CIK 0001616626 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 273,821 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| May 14, 2021 Filed May 19, 2021 00:11 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 448,942 | $81.04 | $36,382,259.68 |
DisclosureSEC source: 0001140361-21-017938 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Double Eagle Investor Holdings, L.P. · CIK 0001712399 · 10% owner Double Eagle GP, LLC · CIK 0001712398 · 10% owner Advent International GPE VIII-C Limited Partnership · CIK 0001664591 · 10% owner GPE VIII GP S.a.r.l. · CIK 0001764293 · 10% owner GPE VIII GP Limited Partnership · CIK 0001714525 · 10% owner Advent International GPE VIII, LLC · CIK 0001713142 · 10% owner GPE VII GP S.a.r.l. · CIK 0001764292 · 10% owner GPE VII GP Limited Partnership · CIK 0001616580 · 10% owner Advent International GPE VII, LLC · CIK 0001616626 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 6,307,489 F1 · kind: See Exhibit 99.1 for text of footnote (1). F2 · shares: See Exhibit 99.1 for text of footnote (2). F3 · balance_after: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| May 06, 2021 Filed May 11, 2021 01:46 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 216,666 | $81.04 | $17,558,612.64 |
DisclosureSEC source: 0001140361-21-016732 · form4.xml · nonDerivative · entry 2 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Double Eagle Investor Holdings, L.P. · CIK 0001712399 · 10% owner Double Eagle GP, LLC · CIK 0001712398 · 10% owner Advent International GPE VIII-C Limited Partnership · CIK 0001664591 · 10% owner GPE VIII GP S.a.r.l. · CIK 0001764293 · 10% owner GPE VIII GP Limited Partnership · CIK 0001714525 · 10% owner Advent International GPE VIII, LLC · CIK 0001713142 · 10% owner GPE VII GP S.a.r.l. · CIK 0001764292 · 10% owner GPE VII GP Limited Partnership · CIK 0001616580 · 10% owner Advent International GPE VII, LLC · CIK 0001616626 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 6,756,431 F3 · kind: See Exhibit 99.1 for text of footnote (3). F2 · shares: See Exhibit 99.1 for text of footnote (2). F3 · balance_after: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| May 06, 2021 Filed May 11, 2021 01:46 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,791,652 | $81.04 | $307,275,478.08 |
DisclosureSEC source: 0001140361-21-016732 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Double Eagle Investor Holdings, L.P. · CIK 0001712399 · 10% owner Double Eagle GP, LLC · CIK 0001712398 · 10% owner Advent International GPE VIII-C Limited Partnership · CIK 0001664591 · 10% owner GPE VIII GP S.a.r.l. · CIK 0001764293 · 10% owner GPE VIII GP Limited Partnership · CIK 0001714525 · 10% owner Advent International GPE VIII, LLC · CIK 0001713142 · 10% owner GPE VII GP S.a.r.l. · CIK 0001764292 · 10% owner GPE VII GP Limited Partnership · CIK 0001616580 · 10% owner Advent International GPE VII, LLC · CIK 0001616626 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 6,973,097 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 23:53 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 322,824 | $74.18 | $23,945,470.20 |
DisclosureSEC source: 0001140361-21-007539 · form4.xml · nonDerivative · entry 2 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Double Eagle Investor Holdings, L.P. · CIK 0001712399 · 10% owner Double Eagle GP, LLC · CIK 0001712398 · 10% owner Advent International GPE VIII-C Limited Partnership · CIK 0001664591 · 10% owner GPE VIII GP S.a.r.l. · CIK 0001764293 · 10% owner GPE VIII GP Limited Partnership · CIK 0001714525 · 10% owner Advent International GPE VIII, LLC · CIK 0001713142 · 10% owner GPE VII GP S.a.r.l. · CIK 0001764292 · 10% owner GPE VII GP Limited Partnership · CIK 0001616580 · 10% owner Advent International GPE VII, LLC · CIK 0001616626 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 10,764,749 F3 · kind: See Exhibit 99.1 for text of footnote (3). F2 · shares: See Exhibit 99.1 for text of footnote (2). F3 · balance_after: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 23:53 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 4,331,222 | $74.18 | $321,268,391.85 |
DisclosureSEC source: 0001140361-21-007539 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Double Eagle Investor Holdings, L.P. · CIK 0001712399 · 10% owner Double Eagle GP, LLC · CIK 0001712398 · 10% owner Advent International GPE VIII-C Limited Partnership · CIK 0001664591 · 10% owner GPE VIII GP S.a.r.l. · CIK 0001764293 · 10% owner GPE VIII GP Limited Partnership · CIK 0001714525 · 10% owner Advent International GPE VIII, LLC · CIK 0001713142 · 10% owner GPE VII GP S.a.r.l. · CIK 0001764292 · 10% owner GPE VII GP Limited Partnership · CIK 0001616580 · 10% owner Advent International GPE VII, LLC · CIK 0001616626 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 11,087,573 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 21:53 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,228,241 | $61.28 | $197,826,608.48 |
DisclosureSEC source: 0001140361-20-027511 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Double Eagle Investor Holdings, L.P. · CIK 0001712399 · 10% owner Double Eagle GP, LLC · CIK 0001712398 · 10% owner Advent International GPE VIII-C Limited Partnership · CIK 0001664591 · 10% owner GPE VIII GP S.a.r.l. · CIK 0001764293 · 10% owner GPE VIII GP Limited Partnership · CIK 0001714525 · 10% owner Advent International GPE VIII, LLC · CIK 0001713142 · 10% owner GPE VII GP S.a.r.l. · CIK 0001764292 · 10% owner GPE VII GP Limited Partnership · CIK 0001616580 · 10% owner Advent International GPE VII, LLC · CIK 0001616626 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 15,418,795 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F2 · balance_after: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). Read SEC document |
| September 17, 2020 Filed Sep 22, 2020 01:53 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,766,281 | $59.26 | $223,189,812.06 |
DisclosureSEC source: 0001140361-20-021060 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Double Eagle Investor Holdings, L.P. · CIK 0001712399 · 10% owner Double Eagle GP, LLC · CIK 0001712398 · 10% owner Advent International GPE VIII-C Limited Partnership · CIK 0001664591 · 10% owner GPE VIII GP S.a.r.l. · CIK 0001764293 · 10% owner GPE VIII GP Limited Partnership · CIK 0001714525 · 10% owner Advent International GPE VIII, LLC · CIK 0001713142 · 10% owner GPE VII GP S.a.r.l. · CIK 0001764292 · 10% owner GPE VII GP Limited Partnership · CIK 0001616580 · 10% owner Advent International GPE VII, LLC · CIK 0001616626 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,647,036 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F2 · balance_after: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). Read SEC document |
| September 17, 2020 Filed Sep 22, 2020 20:33 UTC Amendment | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,766,281 | $59.26 | $223,189,812.06 |
DisclosureSEC source: 0001140361-20-021158 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Double Eagle Investor Holdings, L.P. · CIK 0001712399 · 10% owner Double Eagle GP, LLC · CIK 0001712398 · 10% owner Advent International GPE VIII-C Limited Partnership · CIK 0001664591 · 10% owner GPE VIII GP S.a.r.l. · CIK 0001764293 · 10% owner GPE VIII GP Limited Partnership · CIK 0001714525 · 10% owner Advent International GPE VIII, LLC · CIK 0001713142 · 10% owner GPE VII GP S.a.r.l. · CIK 0001764292 · 10% owner GPE VII GP Limited Partnership · CIK 0001616580 · 10% owner Advent International GPE VII, LLC · CIK 0001616626 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,647,036 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F2 · balance_after: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.